Join the world's largest real-world PRP & Tendon study

Be part of an international, multicenter, scientifically-driven project to transform clinical practice into solid evidence

Over 3,000 patients

100+ international centers

Be part of the solution

Join the study

THE SCIENTIFIC CHALLENGE

Why this matters

Chronic tendinopathies afflict millions of patients worldwide, yet the rapid adoption of platelet-rich plasma (PRP) treatments still outpaces the evidence base: protocols vary widely, product characterization is inconsistent, and follow-up metrics are rarely harmonized. By capturing and analysing large-scale, real-world data across multiple centres, this project delivers the rigorous, standardised evidence needed to turn today’s heterogeneous practice into globally aligned, data-driven care.

Patellar Tendinopathy

Achilles Tendinopathy

Epicondylitis

Plantar Fascitis

study highlights

The largest Real-World PRP Study ever conducted

More than 100 centers worldwide.

Over 3,000 patients.

Real clinical practice.

Minimal disruption to your daily workflow.

Real World Evidence

Real World Evidence (RWE) design: fully integrated into your clinical routine.


PRP Characterization

PRP hematological characterization via automated hematology analyzers


Artifitial Intelligence

AI-powered data analysis identifying predictive response profiles


Scientific impact

High-impact scientific publications planned


Meet the clinical promoter

This international real-world study is coordinated by Dr. Ferrán Abat, one of the world’s leading experts in tendon pathologies and regenerative medicine.



  • Medical Director at ReSport Clinic (Barcelona, Spain)
  • International authority in PRP application for tendon injuries
  • Extensive experience in multicenter clinical research
  • Over 100 peer-reviewed scientific publications in musculoskeletal disorders
  • Active contributor to major scientific societies and international consensus guidelines

This study represents a unique opportunity to finally generate

large-scale, real-world evidence that can drive global

clinical guidelines for PRP treatments in tendon pathologies